Covance Prevails in PETA Lawsuit; Court Enters Order Requiring PETA to Comply With Ban on Infiltration

Covance (NYSE: CVD)
today achieved a successful settlement to its lawsuit against PETA, in which
PETA agreed to a ban on conducting any infiltration of Covance for five years.
In addition, PETA's operative, Lisa Leitten, accepted a three-year ban on
infiltrating any commercial animal research facility worldwide. PETA and
Leitten must also provide all video footage and written notes taken from
Covance. The settlement was confirmed by the Circuit Court of Fairfax County,
which entered an order requiring PETA and Leitten to comply with these
requirements.
"This resolution achieves our key goals of the lawsuit: to obtain a ban on
infiltration and to demonstrate that Covance will not tolerate such unlawful
acts by those who seek to block important biomedical research," said James
Lovett, Senior Vice President and General Counsel at Covance. "The strength
of our case enabled us to achieve these goals quickly via this settlement."
"Our business is devoted to helping develop new medicines for diseases
such as breast cancer, diabetes, leukemia, Alzheimer's, heart disease and
HIV/AIDS," said Lovett. "The research we perform is essential to ensuring
that these medicines are safe and effective before they are made available to
patients."
A copy of the settlement can be found at
http://www.covance.com/animalwelfare/media-resources.php.

Covance, with headquarters in Princeton, New Jersey, is one of the world's
largest and most comprehensive drug development services companies with annual
revenues greater than $1 billion, global operations in 17 countries, and more
than 7,000 employees worldwide. Information on Covance's products and
services, recent press releases, and SEC filings can be obtained through its
website at http://www.covance.com.

Related Articles

• Chamber Calls on House to Help Stop Lawsuit Abuse; Much-Needed Tort Reform Legislation Scheduled for Floor Votes
  19 October 2005



• Liberty Corner Capital Sued in Refco Investor Lawsuit Filed by Shalov Stone & Bonner LLP
  16 October 2005



• Blue Coat Announces Dismissal of Securities Class Action Lawsuit
  15 October 2005



• Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against Tempur-Pedic International, Inc.
  14 October 2005



• Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against AMERIGROUP Corporation
  13 October 2005



• Statement of the United States Concerning Approval of the Settlement of Rosner vs. United States Lawsuit
  12 October 2005



• Nashua Corporation Settles Patent Lawsuit
  12 October 2005



• Smith & Smith LLP Announces Class Action Lawsuit Against Tempur-Pedic International, Inc. -- TPX
  12 October 2005



• Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against Barrier Therapeutics, Inc.
  12 October 2005



• Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Barrier Therapeutics, Inc. -- BTRX
  12 October 2005



• DataDirect Prepares Response to Engenio Lawsuit
  11 October 2005



• Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Boston Scientific Corporation, Announces Class Action Lawsuit And Seeks to Recover
  11 October 2005



• Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Tempur-Pedic International, Inc. -- TPX
  11 October 2005



• Scott+Scott, LLC Updates Shareholder Lawsuit Against Boston Scientific Corporation; Law Firm Drafted Initial Complaint
  8 October 2005



• SAF Demands Answers for Gun Ban at FEMA Relief Center Outside Baton Rouge
  8 October 2005